Ribonuclease as a tumour marker for pancreatic carcinoma

Serum ribonuclease has been measured in 61 patients with a variety of inflammatory and malignant conditions. Serum activity is elevated in pancreatic carcinoma but it is not restricted to this condition. Levels were significantly elevated in cases of disturbed liver function.